Neuronal phospholipid deacylation is essential for axonal and synaptic integrity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 3, 2013, Pages 633-641

  Glynn, Paul ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Axon degeneration; Neurological disease; Phospholipid turnover

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALCIUM INDEPENDENT PHOSPHOLIPASE A2 BETA; CALMODULIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FATTY ACID; GLYCEROPHOSPHOLIPID; LYSOPHOSPHOLIPID; NEUROTOXIC ESTERASE; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

DEACYLATION; ENDOPLASMIC RETICULUM; HEREDITARY MOTOR SENSORY NEUROPATHY; HIPPOCAMPUS; NERVE CELL; NERVE FIBER; NEUROAXONAL DYSTROPHY; NONHUMAN; PHOSPHOLIPID DEACYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SPINAL CORD; SYNAPSE;

ACYLATION; ANIMALS; AXONS; CALCIUM; CALMODULIN; CARBOXYLIC ESTER HYDROLASES; FATTY ACIDS; HUMANS; ISOENZYMES; LYSOPHOSPHOLIPIDS; MICE; NEUROAXONAL DYSTROPHIES; NEUROGLIA; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; SPASTIC PARAPLEGIA, HEREDITARY; SYNAPSES;

EID: 84873110192     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.07.023     Document Type: Review

References (88)

1. M. Murakami, Y. Taketomi, Y. Miki, H. Sato, T. Hirabayashi, and K. Yamamoto Recent progress in phospholipase A2 research: from cells to animals to humans Prog. Lipid Res. 50 2011 152 192
2. M. Karim, P. Jackson, and S. Jackowski Gene structure, expression and identification of a new CTP:phosphocholine cytidylyltransferase beta isoform Biochim. Biophys. Acta 1633 2003 1 12
3. S. Herculano-Houzel, B. Mota, and R. Lent Cellular scaling rules for rodent brains Proc. Natl. Acad. Sci. U. S. A. 103 2006 12138 12143
4. A. Sena, L.L. Sarlieve, and G. Rebel Brain myelin of genetically obese mice J. Neurol. Sci. 68 1985 233 244
5. M.F. Bear, B.W. Connors, and M.A. Paradiso Neuroscience: Exploring the Brain 2nd edition 2001 Lippincott, Williams & Wilkins
6. Y. Sugiura, Y. Konishi, N. Zaima, S. Kajihara, H. Nakanishi, R. Taguchi, and M. Setou Visualization of the cell-selective distribution of PUFA-containing phosphatidylcholines in mouse brain by imaging mass spectrometry J. Lipid Res. 50 2009 1776 1788
7. A. Prinetti, V. Chigorno, S. Prioni, N. Loberto, N. Marano, G. Tettamanti, and S. Sonnino Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro J. Biol. Chem. 276 2001 21136 21145
8. T.A. Rosenberger, N.E. Villacreses, M.A. Contreras, J.V. Bonventre, and S.I. Rapoport Brain lipid metabolism in the cPLA2 knockout mouse J. Lipid Res. 44 2003 109 117
9. S.A. Moore, E. Yoder, S. Murphy, G.R. Dutton, and A.A. Spector Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6) J. Neurochem. 56 1991 518 524
10. U. Igbavboa, J. Hamilton, H.Y. Kim, G.Y. Sun, and W.G. Wood A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes J. Neurochem. 80 2002 255 261
11. J.E. Vance, D. Pan, D.E. Vance, and R.B. Campenot Biosynthesis of membrane lipids in rat axons J. Cell Biol. 115 1991 1061 1068
12. J. Strakova, L. Demizieux, R.B. Campenot, D.E. Vance, and J.E. Vance Involvement of CTP:phosphocholine cytidylyltransferase-beta2 in axonal phosphatidylcholine synthesis and branching of neurons Biochim. Biophys. Acta 1811 2011 617 625
13. H.J. Yang, Y. Sugiura, K. Ikegami, Y. Konishi, and M. Setou Axonal gradient of arachidonic acid-containing phosphatidylcholine and its dependence on actin dynamics J. Biol. Chem. 287 2012 5290 5300
14. M. Van Tienhoven, J. Atkins, Y. Li, and P. Glynn Human neuropathy target esterase catalyses hydrolysis of membrane lipids J. Biol. Chem. 277 2002 20942 20948
15. P.K. Larsson, H.E. Claesson, and B.P. Kennedy Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity J. Biol. Chem. 273 1998 207 214
16. Z. Ma, X. Wang, W. Nowatzke, S. Ramanadham, and J. Turk Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1 J. Biol. Chem. 274 1999 9607 9616
17. P.K. Larsson Forsell, B.P. Kennedy, and H.E. Claesson The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene Eur. J. Biochem. 262 1999 575 585
18. C.M. Jenkins, M.J. Wolf, D.J. Mancuso, and R.W. Gross Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function J. Biol. Chem. 276 2001 7129 7135
19. Y. Li, D. Dinsdale, and P. Glynn Protein domains, catalytic activity and subcellular distribution of neuropathy target esterase in mammalian cells J. Biol. Chem. 278 2003 8820 8825
20. A. Bettencourt da Cruz, J. Wentzell, and D. Kretzschmar Swiss Cheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3 J. Neurosci. 28 2008 10885 10892
21. E.J. Ackermann, E.S. Kempner, and E.A. Dennis Ca(2 +)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization J. Biol. Chem. 269 1994 9227 9233
22. J. Tang, R.W. Kriz, N. Wolfman, M. Shaffer, J. Seehra, and S.S. Jones A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs J. Biol. Chem. 272 1997 8567 8575
23. 2 +-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages J. Biol. Chem. 272 1997 29317 29321
24. O. Zaccheo, D. Dinsdale, P.A. Meacock, and P. Glynn Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells J. Biol. Chem. 279 2004 24024 24033
25. C.M. Jenkins, X. Han, D.J. Mancuso, and R.W. Gross Identification of calcium-independent phospholipase A2 (iPLA2) beta, and not iPLA2gamma, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s J. Biol. Chem. 277 2002 32807 32814
26. M.K. Johnson The delayed neurotoxic action of some organophosphorus compounds. Identification of the phosphorylation site as an esterase Biochem. J. 114 1969 711 717
27. M.K. Johnson The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological implications E. Hodgson, J.R. Bend, R.M. Philpot, Reviews in Biochem. Toxicol. Vol. 4 1982 141 212
28. M. Lotti Organophosphorus compounds P.S. Spencer, H.H. Schaumberg, Experimental and Clinical Neurotoxicology 2nd edition 2000 OUP 897 925
29. M. Eto, J.E. Casida, and T. Eto Hydroxylation and cyclisation reactions involved in the metabolism of tri-o-cresylphosphate Biochem. Pharmacol. 11 1962 337 352
30. J.B. Cavanagh The significance of the "dying-back" process in experimental and human neurological disease Int. Rev. Exp. Pathol. 3 1964 219 267
31. S.-Y. Wu, and J.E. Casida Ethyloctylphosphonofluoridate and analogs: optimized inhibitors of neuropathy target esterase Chem. Res. Toxicol. 8 1995 1070 1075
32. S.-Y. Wu, and J.E. Casida Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors Toxicol. Appl. Pharmacol. 139 1996 195 202
33. C.J. Winrow, M.L. Hemming, D.M. Allen, G.B. Quistad, J.E. Casida, and C. Barlow Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity Nat. Genet. 33 2003 477 485
34. D.J. Read, Y. Li, M.V. Chao, J.B. Cavanagh, and P. Glynn Organophosphates induce distal axonal damage, but not brain oedema, by inactivating neuropathy target esterase Toxicol. Appl. Pharmacol. 245 2010 108 115
35. J. Balsinde, and E.A. Dennis Function and inhibition of intracellular calcium-independent phospholipase A2 J. Biol. Chem. 272 1997 16069 16072
36. I. Baburina, and S. Jackowski Cellular responses to excess phospholipids J. Biol. Chem. 274 1999 9400 9408
37. Z. Ma, S. Ramanadham, M. Wohltmann, A. Bohrer, F.F. Hsu, and J. Turk Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress group VIA phospholipase A2 (iPLA2beta) indicate a signaling rather than a housekeeping role for iPLA2beta J. Biol. Chem. 276 2001 13198 13208
38. C.M. Jenkins, W. Yan, D.J. Mancuso, and R.W. Gross Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoA-mediated reversal of calmodulin inhibition of phospholipase A2 activity J. Biol. Chem. 281 2006 15615 15624
39. S. Bao, C. Jin, S. Zhang, J. Turk, Z. Ma, and S. Ramanadham Beta-cell calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells Diabetes 53 Suppl. 1 2004 S186 S189
40. H.K. Tay, and A.J. Melendez Fcgamma RI-triggered generation of arachidonic acid and eicosanoids requires iPLA2 but not cPLA2 in human monocytic cells J. Biol. Chem. 279 2004 22505 22513
41. 2 +-independent Group VI phospholipase A2s in P388D1 macrophages using GFP/RFP constructs Biochim. Biophys. Acta 1735 2005 119 129
42. H. Song, S. Bao, X. Lei, C. Jin, S. Zhang, J. Turk, and S. Ramanadham Evidence for proteolytic processing and stimulated organelle redistribution of iPLA(2)beta Biochim. Biophys. Acta 1801 2010 547 558
43. J.P.F. Murray, and C.R. McMaster Nte1p-mediated deacylation of phosphatidylcholine functionally interacts with Sec14p J. Biol. Chem. 280 2005 8544 8552
44. H.B. Skinner, T.P. McGee, C.R. McMaster, M.R. Fry, R.M. Bell, and V.A. Bankaitis The Saccharomyces cerevisiae phosphatidylinositol-transfer protein effects a ligand-dependent inhibition of choline-phosphate cytidylyltransferase activity Proc. Natl. Acad. Sci. U. S. A. 92 1995 112 116
45. B.G. Kearns, J.G. Alb Jr., and V. Bankaitis Phosphatidylinositol transfer proteins: the long and winding road to physiological function Trends Cell Biol. 8 1998 276 282
46. Z. Xie, M. Fang, and V.A. Bankaitis Evidence for an intrinsic toxicity of phosphatidylcholine to Sec14p-dependent protein transport from the yeast Golgi complex Mol. Biol. Cell 12 2001 1117 1129
47. A.L. Henneberry, M.M. Wright, and C.R. McMaster The major sites of cellular phospholipid synthesis and molecular determinants of fatty acid and lipid head group specificity Mol. Cell. Biol. 13 2002 3148 3161
48. V. Litvak, N. Dahan, S. Ramachandran, H. Sabanay, and S. Lev Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function Nat. Cell Biol. 7 2005 225 234 Erratum in: Nat Cell Biol. 7, 431
49. D. Peretti, N. Dahan, E. Shimoni, K. Hirschberg, and S. Lev Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport Mol. Biol. Cell 19 2008 3871 3884
50. S. Dremier, R. Kopperud, S.O. Doskeland, J.E. Dumont, and C. Maenhaut Search for new cyclic AMP-binding proteins FEBS Lett. 546 2003 103 107
51. M. Wieprecht, T. Wieder, and C.C. Geilen N-[2-bromocinnamyl(amino)ethyl]- 5-isoquinolinesulphonamide (H-89) inhibits incorporation of choline into phosphatidylcholine via inhibition of choline kinase and has no effect on the phosphorylation of CTP:phosphocholine cytidylyltransferase Biochem. J. 297 1994 241 247
52. Y. Yu, A. Sreenivas, D.B. Ostrander, and G.M. Carman Phosphorylation of Saccharomyces cerevisiae choline kinase on Ser30 and Ser85 by protein kinase A regulates phosphatidylcholine synthesis by the CDP-choline pathway J. Biol. Chem. 277 2002 34978 34986
53. K. Shinzawa, H. Sumi, M. Ikawa, Y. Matsuoka, M. Okabe, S. Sakoda, and Y. Tsujimoto Neuroaxonal dystrophy caused by Group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease J. Neurosci. 28 2008 2212 2220
54. W.Y. Ong, J.F. Yeo, S.F. Ling, and A.A. Farooqui Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain J. Neurocytol. 34 2005 447 458
55. P. Glynn, J.L. Holton, C.C. Nolan, D.J. Read, L. Brown, A. Hubbard, and J.B. Cavanagh Neuropathy target esterase: immunolocalisation to neuronal cell bodies and axons Neuroscience 83 1998 295 302
56. P. Glynn Neural development and neurodegeneration: two faces of neuropathy target esterase Prog. Neurobiol. 61 2000 61 74
57. M. Moser, T. Stempfl, Y. Li, P. Glynn, R. Buettner, and D. Kretzschmar Cloning and expression of the murine sws/NTE gene Mech. Dev. 90 2000 279 282
58. K. Singaravelu, C. Lohr, and J.W. Deitmer Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes J. Neurosci. 26 2006 9579 9592
59. D.J. Read, L. Langford, H.R. Barbour, P.J. Forshaw, and P. Glynn Phospholipase B activity and organophosphorus compound toxicity in cultured neural cells Toxicol. Appl. Pharmacol. 219 2007 190 195
60. 2 +-independent phospholipase A2 from rat brain J. Neurochem. 73 1999 1278 1287
61. R.J. Richardson, C.S. Davis, and M.K. Johnson Subcellular distribution of marker enzymes and neurotoxic esterase in adult hen brain J. Neurochem. 32 1979 607 615
62. K. Akassoglou, B. Malester, J. Xu, L. Tessarollo, J. Rosenbluth, and M. Chao Brain-specific deletion of neuropathy target esterase/Swiss cheese results in neurodegeneration Proc. Natl. Acad. Sci. U. S. A. 101 2004 5075 5080
63. S. Bao, D.J. Miller, Z. Ma, M. Wohltmann, G. Eng, S. Ramanadham, K. Moley, and J. Turk Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility J. Biol. Chem. 279 2004 38194 38200
64. S. Bao, H. Song, M. Wohltmann, S. Ramanadham, W. Jin, A. Bohrer, and J. Turk Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis J. Biol. Chem. 281 2006 20958 20973
65. Y. Cheon, H.W. Kim, M. Igarashi, H.R. Modi, L. Chang, K. Ma, D. Greenstein, M. Wohltmann, J. Turk, S.I. Rapoport, and A.Y. Taha Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA2-beta)-knockout mice Biochim. Biophys. Acta 2012 2012 Feb 10. [Epub ahead of print] PubMed PMID: 22349267
66. M. Moser, Y. Li, K. Vaupel, D. Kretzschmar, R. Kluge, P. Glynn, and R. Buettner Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice Mol. Cell. Biol. 24 2004 1667 1679
67. D.J. Read, Y. Li, M.V. Chao, J.B. Cavanagh, and P. Glynn Neuropathy target esterase is required for adult vertebrate axon maintenance J. Neurosci. 29 2009 11594 11600
68. M. Muhlig-Versen, A.B. da Cruz, J.-A. Tschape, M. Moser, R. Buttner, K. Athenstaedt, P. Glynn, and D. Kretzschmar Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila J. Neurosci. 25 2005 2865 2873
69. N.V. Morgan, S.K. Westaway, J.E. Morton, A. Gregory, P. Gissen, S. Sonek, H. Cangul, J. Coryell, N. Canham, N. Nardocci, G. Zorzi, S. Pasha, D. Rodriguez, I. Desguerre, A. Mubaidin, E. Bertini, R.C. Trembath, A. Simonati, C. Schanen, C.A. Johnson, B. Levinson, C.G. Woods, B. Wilmot, P. Kramer, J. Gitschier, E.R. Maher, and S.J. Hayflick PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron Nat. Genet. 38 2006 752 754 Erratum in: Nat Genet. 2006 Aug;38(8):957
70. N. Nardocci, G. Zorzi, L. Farina, E. Binelli, W. Scaioli, C. Ciaon, L. Verga, L. Angelini, M. Savoiardo, and O. Bugiani Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria Neurology 52 1999 1472 1478
71. C. Paisan-Ruiz, K.P. Bhatia, A. Li, D. Hernandez, M. Davis, N.W. Wood, J. Hardy, H. Houlden, A. Singleton, and S.A. Schneider Characterization of PLA2G6 as a locus for dystonia-parkinsonism Ann. Neurol. 65 2009 19 23
72. L.A. Engel, Z. Jing, D.E. O'Brien, M. Sun, and P.T. Kotzbauer Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism PLoS One 5 9 2010 e12897
73. I. Malik, J. Turk, D.J. Mancuso, L. Montier, M. Wohltmann, D.F. Wozniak, R.E. Schmidt, R.W. Gross, and P.T. Kotzbauer Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations Am. J. Pathol. 172 2008 406 416
74. Z. Zhao, J. Wang, C. Zhao, W. Bi, Z. Yue, and Z.A. Ma Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation PLoS One 6 10 2011 e26991
75. G. Beck, Y. Sugiura, K. Shinzawa, S. Kato, M. Setou, Y. Tsujimoto, S. Sakoda, and H. Sumi-Akamaru Neuroaxonal dystrophy in calcium-independent phospholipase A2beta-deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes J. Neurosci. 31 2011 11411 11420
76. H. Wada, T. Yasuda, I. Miura, K. Watabe, C. Sawa, H. Kamijuku, S. Kojo, M. Taniguchi, I. Nishino, S. Wakana, H. Yoshida, and K. Seino Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6 Am. J. Pathol. 175 2009 2257 2263
77. D.J. Mancuso, P. Kotzbauer, D.F. Wozniak, H.F. Sims, C.M. Jenkins, S. Guan, X. Han, K. Yang, G. Sun, I. Malik, S. Conyers, K.G. Green, R.E. Schmidt, and R.W. Gross Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction J. Biol. Chem. 284 51 2009 35632 35644
78. S. Salinas, C. Proukakis, A. Crosby, and T.T. Warner Hereditary spastic paraplegia: clinical features and pathogenic mechanisms Lancet Neurol. 7 2008 1127 1138
79. G.C. De Luca, G.C. Ebers, and M.M. Esiri The extent of axonal loss in the long tracts in hereditary spastic paraplegia Neuropathol. Appl. Neurobiol. 30 2004 576 584
80. S. Rainier, M. Bui, E. Mark, D. Thomas, D. Tokarz, L. Ming, C. Delanely, R.J. Richardson, J.W. Albers, N. Matsunami, J. Stevens, H. Coon, M. Leppert, and J.K. Fink Neuropathy target esterase mutations cause motor neuron disease Am. J. Hum. Genet. 82 2008 780 785
81. S. Rainier, J.W. Albers, P.J. Dyck, O.P. Eldevik, S. Wilcock, R.J. Richardson, and J.K. Fink Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families Muscle Nerve 43 2011 19 25
82. N.D. Hein, S.R. Rainier, R.J. Richardson, and J.K. Fink Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis Toxicol. Lett. 199 2010 1 5
83. C. Blackstone, C.J. O'Kane, and E. Reid Hereditary spastic paraplegias: membrane traffic and the motor pathway Nat. Rev. Neurosci. 12 2011 31 42 Erratum in: Nat Rev Neurosci. 2011 Feb;12(2):118
84. D.M. Lapadula, S.E. Patton, G.A. Campbell, and M.B. Abou-Donia Characterisation of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate Toxicol. Appl. Pharmacol. 79 1985 83 90
85. M.A. Escudero, and E. Vilanova Purification and characterization of naturally soluble neuropathy target esterase from chicken sciatic nerve by HPLC and western blot J. Neurochem. 69 1997 1975 1982
86. S. Betmouni, J. Clements, and V.H. Perry Vacuolation in murine prion disease: an informative artifact Curr. Biol. 23 1999 R677 R679
87. G.M. Shepherd, and K.M. Harris Three-dimensional structure and composition of CA3→CA1 axons in rat hippocampal slices: implications for presynaptic connectivity and compartmentalization J. Neurosci. 18 20 1998 8300 8310
88. D. Kretzschmar, G. Hasan, S. Sharma, M. Heisenberg, and S. Benzer The Swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila J. Neurosci. 17 1997 7425 7432